ENTERIN
We are a clinical stage biopharmaceutical company engaged in the discovery and development of synthetic derivatives of newly discovered endogenous hormones that target misfolded proteins, including alpha-synuclein in Parkinson’s Disease, or PD, amyloid beta and tau in Alzheimer’s Disease, or AD, as well as targeting insulin resistance which is central to the pathology of Type 2 Diabetes, or T2D, and AD. Our vision is to prevent the onset of these neurodegenerative and metabolic disorders, as well as to slow their progression.
ENTERIN
Social Links:
Industry:
Biopharma Biotechnology Medical
Founded:
2016-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.enterininc.com
Total Employee:
11+
Status:
Active
Contact:
215-372-8031
Total Funding:
70.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
Rion
RION is a clinical-stage regenerative medicine company.
Rznomics
Rznomics is a biotechnology company.
Neomorph
Neomorph is a biotechnology company.
NewStem
NewStem is a biotechnology startup company a spin-off of Yissum.
Novocare
Novocare is a medical equipment research and development company
Vortex Surgical
Vortex Surgical develops surgical disposables and instruments designed to improve the customer experience.
Microvascular Therapeutics
A biotechnology company based in Tucson, Arizona .
MCBI
MCBI is a bioinformatics company.
MetGen
MetGen develops and produces enzymes tailored to industrial customer needs.
Merito
Merito North Carolina based Technology Company.
Mabworks
Mabworks is a gene engineering mab company.
LIG Biowise
Manchester, UK-based biotechnlogy company.
ALGAentis
ALGAentis , inc. , a Colorado C-Corp. , has Patented its automated process and machinery, for producing both Algae biomass.
Ark Bio
Ark Bio is a medical technology company
Eyebiotech
Eyebiotech is a privately held ophthalmology biotechnology company.
EntroGen
EntroGen is a Los Angeles-based biotechnology company
ENYO Pharma
ENYO Pharma is a biopharmaceutical company based in Lyon, France.
Epsilon Molecular Engineering
Epsilon Molecular Engineering is a Biotechnology research and development company.
BioMarck Pharmaceuticals
BioMarck Pharmaceuticals develops new drugs for the treatment of pulmonary diseases.
Biocon
Biocon is a healthcare and technology, company focused on biotechnology.
BIOSA Technologies
BIOSA Technologies is an enzymatic biotechnology company headquartered in Toronto, Canada.
Bioincept
BioIncept develops compound for embryo development in humans.
Falcon Therapeutics
A Chapel Hill-based biotechnology company.
The Bioclinic Group
The Bioclinic Group is a medical company that operates medical analysis laboratories.
Jiksak Bioengineering
Jiksak Bioengineering is a biotechnology company.
Q BioMed
A biomedical acceleration and development company .
Kirkstall
Kirkstall develops ‘in vivo-like’ culture systems providing dynamic conditions for cell growth which are more physiologically accurate.
BeyondSpring Pharmaceuticals
Spring Pharmaceuticals is a biotechnology company based in Duncan, South Carolina.
Scipio Bioscience
A Paris-based biotechnology company .
Silicone Arts Laboratories
Silicone Arts Laboratories develops silicone-based products that enhance a person's physical appearance.
Septerna
Septerna is a biotechnology company.
ScarTec Therapeutics
ScarTec Therapeutics develops novel peptide-based technology for scar-free healing.
Shandong Fuyang Biotech
Shandong fuyang Biotechnology Co., Ltd. is a high-tech enterprise
SystImmune
SystImmune is a biotechnology company.
Danxia
Danxia is a biological blood products developer company.
D Pharm LTD.
D-Pharm is a drug-development company.
HTBT
HTBT is a biopharmaceutical manufacturer that focuses on international biotechnology introduction and absorption.
Huaota Biopharm
Huaota Biopharm develops high-quality biological drugs for the global market.
Inversago Pharma
Inversago Pharma is a specialized, preclinical-stage biotech company.
Imaxio
Imaxio is a France-based biopharmaceutical company specialized in vaccines and genomics.
Geneius
Geneius is a Biotechnology company.
Genia Technologies
Genia Technologies is a biotechnology company.
Gerostate Alpha
Gerostate Alpha is a pharmaceutical company.
Genome Profiling
Genome Profiling company focused on epigenetic biomarker discovery.
OM Pharma
OM Pharma is a global Geneva-based Biotech company.
Chromocenter
Chromocenter is a next generation biopharmaceuticals Manufacturing company.
Collaborative Medicinal Development
Collaborative Medicinal Development is a privately-held biopharmaceutical company.
Core Quantum Technologies
Core Quantum Technologies engages in illuminating cell biology and pathology.
ChronWell
Chronwell is a technology company that ensures the injured worker to get back to work better and faster, at a lower cost.
Cytomos
Cytomos develops and provides integrated, predictive analytics systems for intelligent bioprocessing in biopharma.
Corline Biomedical
Corline Biomedical is a pharmaceutical company based in Sweden.
PurThread Technologies
PurThread Technologies focuses on developing proprietary antimicrobial textile technology.
panCELLa
Toronto based biotechnology company.
Youlong Biotech
Youlong Biotech is a biotechnology company with full-chain service and rapid product testing.
Current Advisors List
Current Employees Featured
Founder
Investors List
New Ventures III
New Ventures III investment in Series B - Enterin
New Ventures III
New Ventures III investment in Series A - Enterin
Key Employee Changes
| Date | New article |
|---|---|
| 2020-10-27 | Enterin Announces Appointment of VP, Head Of Medical And Clinical Development |
| 2020-10-16 | Enterin Announces Appointment of New CEO |
Official Site Inspections
http://www.enterininc.com Semrush global rank: 2.31 M Semrush visits lastest month: 8.1 K
- Host name: vps45061.inmotionhosting.com
- IP address: 173.231.196.35
- Location: El Segundo United States
- Latitude: 33.9214
- Longitude: -118.413
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90245
More informations about "Enterin"
Enterin - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 215-372-8031 We are a clinical stage biopharmaceutical company engaged in the discovery and development of synthetic …See details»
Gut-Brain Axis and Neurodegenerative Disease - Enterin
We are a clinical stage biopharmaceutical company pioneering novel treatments that target the gut-brain axis and modify the course of neurodegenerative disorders. Our research has aided …See details»
Leadership - Enterin
He is a physician-scientist, inventor, professor, health care leader, and entrepreneur. Dr. Larson founded and served as the director of the Clinical and Translational Science Center in New Mexico for 17 years, an organization that …See details»
Enterin Inc. - LinkedIn
Enterin Inc. | 1,265 followers on LinkedIn. Improving the quality of life of patients with neurodegenerative conditions by repairing the gut-brain axis. | Enterin is the first company in the world ...See details»
Enterin Announces New Funding and Appointment of David
Mar 10, 2022 He is the Co-Founder/Trustee of the VoLo Foundation, a philanthropic organization supporting data driven research and projects with a focus on climate change and …See details»
Enterin Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Enterin. Use the PitchBook Platform to explore the full profile.See details»
Enterin: treating Parkinson’s disease by restoring gut
Enterin, Inc. Denise Barbut, Cofunder, Presidentand CMO, Enterin, Inc, Philadelphia, PA, USA, Tel: +1-215-634-9243, Website: www.enterininc.comSee details»
Enterin Announces New Funding and Appointment of David Vogel …
PHILADELPHIA, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Enterin Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company developing novel treatments for …See details»
Working At Enterin: Company Overview and Culture - Zippia
Mar 14, 2024 enterininc.com. Organization Type. Private. CEO. David McCullough. Enterin Inc. is the first company in the world to develop a novel drug that repairs the dysfunctional gut …See details»
News and Press Releases - Enterin
Jun 24, 2023 Results can be found online at www.enterininc.com and at https: ... He is the Co-Founder/Trustee of the VoLo Foundation, a philanthropic organization supporting data driven …See details»
Enterin - Overview, News & Similar companies | ZoomInfo.com
Enterin contact info: Phone number: (202) 444-6396 Website: www.enterininc.com What does Enterin do? Enterin Inc. is the first company to develop novel compounds that repair the …See details»
Enterin Announces the Start of a First-in-Human Study of ENT-03 …
PHILADELPHIA, June 05, 2023 (GLOBE NEWSWIRE) -- Enterin Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company pioneering novel treatments for …See details»
Enterin announces FDA acceptance of an investigator
PHILADELPHIA, May 31, 2023 (GLOBE NEWSWIRE) -- Enterin Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company pioneering...See details»
Enterin and Parkinson’s UK Announce Research Collaboration
Oct 13, 2022 For more information, please visit www.enterininc.com. About Parkinson’s and Parkinson’s UK Parkinson’s is the fastest growing neurological condition in the world.See details»
Board of Directors - Enterin
Mark Finn Board Member. Mark Finn has 49 years of investment experience. In 1975, Mark joined the predecessor to the Vantage Consulting Group as an outside consultant and was elected its …See details»
Enterin: treating Parkinson’s disease by restoring gut ... - Nature
Email: [email protected] contact Enterin, Inc. www.enterininc.com Fig. 1| Action of ENT-01 inside the cell. A protein similar in biophysical characteristics to α-synuclein is expressed in …See details»
Advisors - Enterin
Professor and Head of Department of Old Age Psychiatry, Institute of Psychiatry, Psychology and Neuroscience. Research Director, Centre for Age-Related Medicine, Stavanger University …See details»
Enterin Meets Study Endpoints for the Phase 2b (KARMET)
PHILADELPHIA, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Enterin Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company pioneering novel treatments for …See details»
ENT-03 - Drug Targets, Indications, Patents - Synapse
The second compound, ENT-03, increases insulin sensitivity by acting at the level of the brain. It is being developed for the treatment of diabetes, obesity, and Alzheimer’s disease. For more …See details»